Rigel Pharmaceuticals, Inc. (RIGL) Reports In-Line Q1 Loss
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $1.13 --0%
EPS Growth %: +62.5%
Financial Fact:
Interest income: 110K
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: +62.5%
Financial Fact:
Interest income: 110K
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Ryder System (R) Tops Q1 EPS by 43c
- Fiserv (FI) Tops Q1 EPS by 9c; Boosts outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
